Results 51 to 60 of about 1,365,991 (387)

Antidepressant drugs and the response in the placebo group: the real problem lies in our understanding of the issue [PDF]

open access: yes, 2012
In a recent paper, Horder and colleagues (Horder et al., 2010, J Psychopharmacol 25: 1277–1288) have suggested that the mainproblem in the Kirsch analysis is methodological. We argue that the results are similar irrespective of the method used.
Bech P   +8 more
core   +1 more source

Two Phase 3 Trials of Dupilumab versus Placebo in Atopic Dermatitis.

open access: yesNew England Journal of Medicine, 2016
BACKGROUND Dupilumab, a human monoclonal antibody against interleukin-4 receptor alpha, inhibits signaling of interleukin-4 and interleukin-13, type 2 cytokines that may be important drivers of atopic or allergic diseases such as atopic dermatitis ...
E. Simpson   +24 more
semanticscholar   +1 more source

Improving osteoporosis treatment rates in inpatients admitted with hip fracture: A healthcare improvement initiative in a tertiary referral hospital

open access: yesAGING MEDICINE, Volume 5, Issue 4, Page 264-271, December 2022., 2022
Our hospital introduced a standardized protocol for the treatment of osteoporosis in patients admitted for hip fracture. The aim of this article was to describe its implementation as well as assess the protocol's effect on treatment rates and safety. In our analysis, there was significant improvement in treatment rates with no instances of acute kidney
Andrew Gan Lin   +5 more
wiley   +1 more source

Illness Expectations Assessment in People with Asthma: A Tool for Explicit and Implicit Beliefs

open access: yesJournal of Asthma and Allergy, 2021
Francesco Pagnini,1,2 Eleonora Volpato,1,3 Silvia Dell’Orto,1 Cesare Cavalera,1 MariaFrancesca Spina,3 Paolo Banfi3 1Department of Psychology, Università Cattolica del Sacro Cuore, Milan, Italy; 2Department of Psychology, Harvard University,
Pagnini F   +5 more
doaj  

Error-related negativity and the misattribution of state-anxiety following errors: On the reproducibility of Inzlicht and Al-Khindi (2012)

open access: yesFrontiers in Human Neuroscience, 2016
In their innovative study, Inzlicht and Al-Khindi (2012) demonstrated that participants who were allowed to misattribute their arousal and negative affect induced by errors to a placebo beverage had a reduced error-related negativity (ERN/Ne) compared to
Carmen Cano Rodilla   +2 more
doaj   +1 more source

Developing a Rational, Optimized Product of Centella asiatica for Examination in Clinical Trials: Real World Challenges

open access: yesFrontiers in Nutrition, 2022
Botanical products are frequently sold as dietary supplements and their use by the public is increasing in popularity. However, scientific evaluation of their medicinal benefits presents unique challenges due to their chemical complexity, inherent ...
Kirsten M. Wright   +14 more
doaj   +1 more source

Can Intracommunicology Assist the Philosophy of the Media? [PDF]

open access: yesIn Medias Res, 2020
In 2014, the famous researcher and Nobel laureate Bruce Lipton proved that human thoughts, not just thinking, are energy, they are real and have power. “‘Do not doubt that you command your body and mind... If thoughts are weak and life is like that.
Fahira Fejzić-Čengić
doaj   +1 more source

A Randomized, Controlled, Phase 2 Study of Maralixibat in the Treatment of Itching Associated With Primary Biliary Cholangitis. [PDF]

open access: yes, 2019
Primary biliary cholangitis (PBC) is typically associated with elevated serum bile acid levels and pruritus, but pruritus is often refractory to treatment with existing therapies.
Apostol, George   +15 more
core   +2 more sources

Lenvatinib versus placebo in radioiodine-refractory thyroid cancer.

open access: yesNew England Journal of Medicine, 2015
BACKGROUND Lenvatinib, an oral inhibitor of vascular endothelial growth factor receptors 1, 2, and 3, fibroblast growth factor receptors 1 through 4, platelet-derived growth factor receptor α, RET, and KIT, showed clinical activity in a phase 2 study ...
M. Schlumberger   +18 more
semanticscholar   +1 more source

A pilot randomized controlled trial of WeiNaoKang (SaiLuoTong) in treating vascular dementia

open access: yesAGING MEDICINE, Volume 5, Issue 4, Page 246-256, December 2022., 2022
A 16‐week randomized double‐blind, placebo‐controlled trial for vascular dementia was carried out with WeiNaoKang (or SaiLuoTong). There were significant differences in improvement in cognitive function and activities of daily living, favouring the treatment group.
Junguang Liu   +6 more
wiley   +1 more source

Home - About - Disclaimer - Privacy